Hyline Oral Drops contain Hydroxyzine at a concentration of 6 mg/ml, an antihistamine with anxiolytic, sedative, and antiemetic properties. This medication is primarily indicated for the symptomatic relief of anxiety and tension associated with psychoneurosis, as well as for the management of pruritus due to allergic conditions such as chronic urticaria and atopic dermatitis. Hydroxyzine acts by inhibiting the activity of histamine at H1 receptor sites, thereby reducing allergic symptoms and exerting a central nervous system depressant effect that alleviates anxiety and induces sedation. Hyline Oral Drops are administered orally, allowing for flexible dosing in both pediatric and adult patients as directed by a healthcare professional. The onset of action typically occurs within 15 to 30 minutes, making it suitable for acute symptom management. Caution is advised in patients with a history of hypersensitivity to hydroxyzine or other antihistamines, as well as those with impaired hepatic or renal function. Concomitant use with central nervous system depressants may potentiate sedative effects. Common adverse reactions include drowsiness, dry mouth, and headache. Hyline Oral Drops should be used under medical supervision to ensure appropriate dosing and to monitor for potential side effects.